Visioneering Technologies (ASX:VTI) Debt-to-Equity : 0.00 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies Debt-to-Equity?

Visioneering Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Visioneering Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Visioneering Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$8.60 Mil. Visioneering Technologies's debt to equity for the quarter that ended in Dec. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Visioneering Technologies's Debt-to-Equity or its related term are showing as below:

ASX:VTI' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.27 Med: 0.23 Max: 2.92
Current: 0.2

During the past 7 years, the highest Debt-to-Equity Ratio of Visioneering Technologies was 2.92. The lowest was -2.27. And the median was 0.23.

ASX:VTI's Debt-to-Equity is ranked better than
51.34% of 711 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs ASX:VTI: 0.20

Visioneering Technologies Debt-to-Equity Historical Data

The historical data trend for Visioneering Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies Debt-to-Equity Chart

Visioneering Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

2.92

-2.27

0.27

0.19

Visioneering Technologies Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial									0.27	0.39	0.19	0.25	-

Competitive Comparison of Visioneering Technologies's Debt-to-Equity

For the Medical Devices subindustry, Visioneering Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visioneering Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Visioneering Technologies's Debt-to-Equity falls into.

Visioneering Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Visioneering Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	8.602
	=	0.00

Visioneering Technologies's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	8.602
	=	0.00

Visioneering Technologies (ASX:VTI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Visioneering Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Visioneering Technologies (ASX:VTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10745 Westside Way, Suite 200, Alpharetta, GA, USA, 30009

Website

http://www.vtivision.com

Visioneering Technologies Inc is a medical device company. It designs, manufactures, sales and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision and which is much easier for eye care professionals to fit their patients.